After-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS

September 22, 2022 5:46 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

After-Hours Stock Movers:

Spectrum Pharmaceuticals (Nasdaq: SPPI) 28% LOWER; The FDA's Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations. The committee voted 9-4 that the current benefits of poziotinib did not outweigh its risks.

Avenue Therapeutics, Inc. (Nasdaq: ATXI) 24% HIGHER; announced that it will effect a 1-for-15 reverse split of its common stock.

Cano Health, Inc. (NYSE: CANO) 5% HIGHER; adds to 32% intra-day gains on reports it is for sale with multiple bidders.

Calamp Corp. (NASDAQ: CAMP) 4% HIGHER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $69.27 million.

Costco (NASDAQ: COST) 3% LOWER; reported Q4 EPS of $4.20, $0.05 better than the analyst estimate of $4.15. Revenue for the quarter came in at $72.09 billion versus the consensus estimate of $71.64 billion.

Guidewire (NYSE: GWRE) 3% HIGHER; announced that its board of directors approved a share repurchase program with authorization to purchase up to $400.0 million of its outstanding shares of Common Stock, effective immediately.

Trevi Therapeutics, Inc. (Nasdaq: TRVI) 2% LOWER; commenced an underwritten public offering of shares of its common stock.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

After-Hours Movers, AdCom, FDA